A. Juarez-Garcia

The costs of epilepsy misdiagnosis in England and Wales

A. Juarez-Garcia, Tim Stokes, Beth Shaw et al. · Seizure · 2006 · 68 citations

Medicine, Neurology, Pharmacoeconomics +7

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

Ian Koblbauer, Najida Begum, George Dranitsaris et al. · PharmacoEconomics · 2017 · 65 citations · Full text

Public Health, Biostatistics, Oncology +17

Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care

David Turner, Sanjoy K. Paul, Margaret Stone et al. · Heart · 2008 · 53 citations

Pharmacy, Cardiology, Pharmacoeconomics +17

Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial

Elizabeth Dormandy, Stirling Bryan, A. E. Ades et al. · Health Technology Assessment · 2010 · 35 citations · Full text

Medicine, Maternal Health, Public Health Practice +17

Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

Edward Gibson, Najida Begum, Ian Koblbauer et al. · Journal of Medical Economics · 2019 · 25 citations · Full text

Pharmacy, Biostatistics, Oncology +17